传统西藏医学:在肺部疾病中的治疗潜力
Canlin Li1, Yuan Li2, Xi Huang2
1School of Ethnic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Frontiers in pharmacology
|April 3, 2024
概括
西藏医学为肺部疾病提供丰富的自然疗法. 本次审查强调了33种有效的西藏药物,重点关注它们的民族医学,植物化学和药理学特性,以便在未来开发药物.
科学领域:
- 传统医学的传统医学.
- 药理学 药理学是指药理学的学科.
- 肺部病理学 肺部病理学
背景情况:
- 肺部疾病对全球健康构成重大挑战.
- 对许多肺部疾病的有效药物治疗仍然有限.
- 西藏医学是一种传统实践,长期以来一直有效治疗肺部疾病.
研究的目的:
- 编制和审查用于肺部疾病的西藏药物.
- 研究关键藏药的民族医学,植物化学和药理学特性.
- 为开发新型肺病治疗方法提供参考.
主要方法:
- 文献研究包括25个古典藏医文本,药物标准和数据库.
- 藏药汇编,包括586种藏药.
- 深入审查四种常用和五种经常使用的西藏药物用于肺部疾病.
主要成果:
- 通过广泛的文献审查确定了586种西藏药物.
- 已确认33种藏药在治疗肺部疾病方面表现出有效性.
- 详细审查特定的西藏药物,包括罗迪奥拉,,海,李祥杜胡安,红杉,甘,桑达木,科斯图斯和米罗巴兰.
结论:
- 西藏医学为肺部疾病治疗提供了宝贵的资源.
- 对已识别的西藏药物的进一步研究可以指导新药的开发.
- 本综述为探索基于传统西藏疗法治疗肺部疾病的新型治疗策略提供了基础.
更多相关视频
05:56A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
Published on: May 12, 2023
3.4K
05:19Author Spotlight: An Effective Traditional Chinese Medicinal Treatment for Chronic Obstructive Pulmonary Disease with Abdominal Distension
Published on: September 1, 2023
1.4K
相关概念视频
Drugs Used in Lower Respiratory Disorders: Overview
437
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
437
Other Pulmonary Disorders
837
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
837
COPD: Management Using Bronchodilators and Corticosteroids
202
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
202
Pulmonary Tuberculosis V
179
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
179
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
